The latest price target for cbdMD (AMEX:YCBD) was reported by Maxim Group on October 5, 2023. The analyst firm set a price target for $3.00 expecting YCBD to rise to within 12 months (a possible 408.47% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for cbdMD (AMEX:YCBD) was provided by Maxim Group, and cbdMD initiated their buy rating.

There is no last upgrade for cbdMD

There is no last downgrade for cbdMD.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of cbdMD, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for cbdMD was filed on October 5, 2023 so you should expect the next rating to be made available sometime around October 5, 2024.

While ratings are subjective and will change, the latest cbdMD (YCBD) rating was a initiated with a price target of $0.00 to $3.00. The current price cbdMD (YCBD) is trading at is $0.59, which is within the analyst’s predicted range.